Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.

British journal of cancer - 1 Dec 2000

Austrup F, Uciechowski P, Eder C, Böckmann B, Suchy B, Driesel G, Jäckel S, Kusiak I, Grill H J, Giesing M

Abstract excerpt

The prognostic value of disseminated tumour cells derived from 353 breast cancer patients was evaluated. Disseminated tumour cells were purified from blood using a newly established method and nucleic acids were subsequently isolated. We investigated genomic imbalances (GI) such as mutation, amplification and loss of heterozygosity of 13 tumour suppressor genes and 2 proto-oncogenes using DNA from isolated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Adhesion Molecules
Share to DCC Receptor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Neoplasm, Residual

Share to Neoplastic Cells, Circulating

Share to Proto-Oncogene Proteins c-myc

Share to Receptor, ErbB-2

Share to Retinoblastoma Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 11104564
DOI: 10.1054/bjoc.2000.1501
PMCID: PMC2363462

Genes

DCC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.PMID 11104564Read ↗

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression.Semantic proximity Read ↗

Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer ProgressionSemantic proximity Read ↗

High‐resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancerSemantic proximity Read ↗

Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer PatientsSemantic proximity Read ↗

Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance.Semantic proximity Read ↗

Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells.Semantic proximity Read ↗

Tumor-specific DNA in plasma of breast cancer patients.Semantic proximity Read ↗

Disseminated tumor cells: diagnosis, prognostic relevance, and phenotyping.Semantic proximity Read ↗

Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancerSemantic proximity Read ↗

Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions.Semantic proximity Read ↗

Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.Semantic proximity Read ↗

Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.